Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E37.24 EPS (ttm)2.29 Insider Own1.09% Shs Outstand50.79M Perf Week-1.00%
Market Cap4.34B Forward P/E15.68 EPS next Y5.43 Insider Trans-5.42% Shs Float50.40M Perf Month-8.58%
Income117.56M PEG3.10 EPS next Q1.01 Inst Own101.13% Short Float6.48% Perf Quarter6.10%
Sales1.31B P/S3.32 EPS this Y16.06% Inst Trans-0.60% Short Ratio6.01 Perf Half Y-2.98%
Book/sh18.90 P/B4.51 EPS next Y18.22% ROA5.69% Short Interest3.26M Perf Year0.88%
Cash/sh3.51 P/C24.28 EPS next 5Y12.00% ROE13.22% 52W Range70.74 - 97.97 Perf YTD-0.37%
Dividend Est.2.00 (2.35%) P/FCF37.60 EPS past 5Y17.09% ROI6.48% 52W High-13.04% Beta0.30
Dividend TTM- Quick Ratio1.50 Sales past 5Y6.80% Gross Margin51.41% 52W Low20.43% ATR (14)2.31
Dividend Ex-Date- Current Ratio2.56 EPS Y/Y TTM1.99% Oper. Margin15.63% RSI (14)43.16 Volatility1.92% 2.70%
Employees3657 Debt/Eq0.91 Sales Y/Y TTM12.01% Profit Margin8.98% Recom1.43 Target Price113.29
Option/ShortYes / Yes LT Debt/Eq0.89 EPS Q/Q-30.93% Payout0.00% Rel Volume1.10 Prev Close85.50
Sales Surprise4.18% EPS Surprise0.92% Sales Q/Q12.77% EarningsMay 09 BMO Avg Volume543.00K Price85.19
SMA20-1.48% SMA50-4.15% SMA2000.35% Trades Volume599,547 Change-0.36%
Date Action Analyst Rating Change Price Target Change
Jun-12-24Upgrade Needham Hold → Buy $112
Oct-13-22Initiated Mizuho Buy $90
Jan-27-22Downgrade Needham Buy → Hold
Dec-15-21Downgrade Citigroup Buy → Neutral $75 → $59
Aug-17-21Resumed Raymond James Outperform $75
Jun-17-21Initiated Citigroup Buy $75
May-14-21Upgrade CJS Securities Market Perform → Market Outperform
Apr-20-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade CJS Securities Market Outperform → Market Perform
Feb-03-21Upgrade Barrington Research Mkt Perform → Outperform $140
Jun-19-24 01:26PM
Jun-18-24 04:15PM
Jun-14-24 09:40AM
Jun-13-24 10:19AM
09:45AM Loading…
Jun-03-24 09:45AM
May-30-24 02:41AM
May-29-24 09:40AM
May-27-24 12:45PM
May-24-24 09:55AM
May-23-24 12:00PM
May-22-24 09:13AM
04:05PM Loading…
May-21-24 04:05PM
May-17-24 12:00PM
May-14-24 09:15AM
May-13-24 09:40AM
May-10-24 03:57PM
May-09-24 10:55AM
09:15PM Loading…
May-08-24 09:15PM
May-06-24 09:16AM
May-01-24 11:51AM
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
Feb-18-24 01:26PM
Feb-09-24 10:39AM
Feb-08-24 10:00PM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
Jan-11-24 04:05PM
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
Nov-23-23 09:45AM
Nov-10-23 12:45PM
Nov-06-23 09:45AM
Nov-05-23 02:30PM
Nov-03-23 10:31AM
Nov-02-23 09:30AM
Nov-01-23 06:27PM
Oct-26-23 10:02AM
Oct-20-23 12:45PM
Oct-19-23 11:49AM
Oct-18-23 11:10AM
Oct-17-23 11:17AM
Oct-16-23 08:28AM
Oct-13-23 10:05AM
Oct-12-23 12:04PM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Simon, ChristopherPresident & CEOJun 06 '24Option Exercise41.64104,5164,352,046433,877Jun 07 04:15 PM
Basil Michelle LEVP and General CounselMay 29 '24Sale88.0812,9901,144,20831,257May 29 05:38 PM
Strong Stewart WPresident, Global HospitalMay 29 '24Sale87.538,857775,25318,196May 29 05:27 PM
Strong Stewart WPresident, Global HospitalMay 20 '24Option Exercise56.572,241126,77320,437May 21 06:01 PM
Basil Michelle LEVP and General CounselMay 20 '24Sale95.081,604152,50831,257May 21 05:46 PM
Llorens JosepEVP, Global ManufacturingMay 20 '24Sale95.0898793,84421,310May 21 05:52 PM
Strong Stewart WPresident, Global HospitalMay 20 '24Sale95.1168665,24518,196May 21 06:01 PM
Basil Michelle LEVP and General CounselMay 17 '24Sale95.001,073101,93529,352May 21 05:46 PM
Llorens JosepEVP, Global ManufacturingMay 17 '24Sale94.8282277,94216,350May 21 05:52 PM
Strong Stewart WPresident, Global HospitalMay 16 '24Option Exercise57.602,410138,81618,018May 17 05:11 PM
Basil Michelle LEVP and General CounselMay 16 '24Sale96.1498594,69830,425May 17 05:02 PM
Llorens JosepEVP, Global ManufacturingMay 16 '24Sale96.1477074,02817,172May 17 04:55 PM
Strong Stewart WPresident, Global HospitalMay 16 '24Sale96.0473370,39715,608May 17 05:11 PM
Lingamneni AnilaEVP, Chief Technology OfficerMay 06 '24Sale95.002,305218,97512,295May 08 04:21 PM
Strong Stewart WPresident, Global HospitalSep 12 '23Sale90.6522820,66816,221Sep 13 04:19 PM
Lingamneni AnilaEVP, Chief Technology OfficerSep 11 '23Sale90.002,305207,45014,495Sep 13 04:20 PM
Dockendorff Charles JDirectorSep 05 '23Sale87.6810,215895,6512,226Sep 07 04:23 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Option Exercise57.104,928281,39023,391Jul 20 04:17 PM
Llorens JosepEVP, Global ManufacturingJul 18 '23Sale90.004,928443,52018,463Jul 20 04:17 PM
Simon, ChristopherPresident & CEOJun 29 '23Option Exercise28.61196,7465,629,887414,113Jun 30 04:17 PM